scholarly journals Medication adherence decision-making among adolescents and young adults with cancer

2016 ◽  
Vol 20 ◽  
pp. 207-214 ◽  
Author(s):  
Meghan E. McGrady ◽  
Gabriella A. Brown ◽  
Ahna L.H. Pai
2012 ◽  
Vol 17 (5) ◽  
pp. 797-808 ◽  
Author(s):  
Cynthia Fair ◽  
Lori Wiener ◽  
Sima Zadeh ◽  
Jamie Albright ◽  
Claude Ann Mellins ◽  
...  

2011 ◽  
Vol 2 ◽  
Author(s):  
David J. Paulsen ◽  
Michael L. Platt ◽  
Scott A. Huettel ◽  
Elizabeth M. Brannon

2022 ◽  
pp. 275275302110687
Author(s):  
Kimberly A. Pyke-Grimm ◽  
Linda S. Franck ◽  
Bonnie Halpern-Felsher ◽  
Robert E. Goldsby ◽  
Roberta S. Rehm

Background: Adolescents and young adults (AYAs) with cancer must negotiate the transition between childhood and adulthood while dealing with a life-threatening illness. AYA involvement in decision making varies depending on the type of decision and when decisions occur during treatment, and evidence suggests that AYAs want to be involved in decision making. Objective: To explore involvement of AYAs with cancer in day-to-day decisions affected by their cancer and treatment. Methods: This qualitative study used interpretive focused ethnography within the sociologic tradition, informed by symbolic interactionism. Semi-structured interviews and informal participant observation took place at two quaternary pediatric oncology programs. Results: Thirty-one interviews were conducted with 16 AYAs ages 15 to 20 years. Major day to day decision-making categories identified included: (1) mental mindset, (2) self-care practices, (3) self-advocacy, and (4) negotiating relationships. Participants described how they came to grips with their illness early on and decided to fight their cancer. They described decisions they made to protect their health, how they advocated for themselves and decisions they made about relationships with family and friends. Conclusions: Through day-to-day decisions, participants managed the impact of cancer and its treatment on their daily lives. Research should focus on developing and implementing interventions to empower AYAs to participate in day-to-day decisions that will affect how they manage their cancer, its treatment and ultimately their outcomes. Implications for Practice: Healthcare providers can facilitate AYA's participation in day-to-day decision making through encouraging autonomy and self-efficacy by providing support and through effective communication.


2019 ◽  
Vol 28 (7) ◽  
pp. 1408-1419 ◽  
Author(s):  
Danielle Gessler ◽  
Ilona Juraskova ◽  
Ursula M. Sansom‐Daly ◽  
Heather L. Shepherd ◽  
Pandora Patterson ◽  
...  

2019 ◽  
Vol 64 (2) ◽  
pp. S104
Author(s):  
Diane Chen ◽  
Moira A. Kyweluk ◽  
Afiya Sajwani ◽  
Elisa J. Gordon ◽  
Emilie K. Johnson ◽  
...  

2014 ◽  
Vol 21 (2) ◽  
pp. 191-205 ◽  
Author(s):  
Idia B. Thurston ◽  
Laura M. Bogart ◽  
Madeline Wachman ◽  
Elizabeth F. Closson ◽  
Margie R. Skeer ◽  
...  

2011 ◽  
Vol 39 (1) ◽  
pp. 174-179 ◽  
Author(s):  
TRACY V. TING ◽  
DEEPA KUDALKAR ◽  
SHANNEN NELSON ◽  
SANDRA CORTINA ◽  
JOSHUA PENDL ◽  
...  

Objective.In a cohort of 70 patients with childhood-onset systemic lupus erythematosus (cSLE): to determine the baseline adherence to medications and visits; to investigate the effects of cellular text messaging reminders (CTMR) on adherence to clinic visits; and to study the influence of CTMR on adherence to use of hydroxychloroquine (HCQ).Methods.CTMR were sent to 70 patients prior to clinic visits for 14 months. A subgroup of patients were evaluated for medication adherence to HCQ: 19 patients receiving CTMR prior to each scheduled HCQ dose were compared to 22 patients randomized to standard of care education about HCQ. Visit adherence was measured using administrative databases. Pharmacy refill information, self-report of adherence, and HCQ blood levels were utilized to monitor medication adherence to HCQ. Sufficient adherence to visits or HCQ was defined as estimates > 80%. Disease activity was primarily monitored with the Systemic Lupus Erythematosus Disease Activity Index.Results.At baseline, 32% of patients were sufficiently adherent to HCQ, and 81% to clinic visits. Visit adherence improved significantly by > 80% among those who were nonadherent to clinic visits at the baseline CTMR (p = 0.01). CTMR did not influence adherence to HCQ over time.Conclusion.Patients with cSLE were only modestly adherent to HCQ and clinic visits. CTMR may be effective for improving visit adherence among adolescents and young adults with cSLE, but it does not improve adherence to HCQ.


Sign in / Sign up

Export Citation Format

Share Document